mwanahisa wrote:I respect msimon's views on insurance matters. However, in this case he is misrepresenting some issues. But right now I am quite happy for him to do as it might just enable me to get this stock cheap. I will refute them once I have my fill of the share. Selfish? Of course, but that's the way of the world!
mwanahisa- indeed i may be wrong on some matters no doubt, but i wouldn't be a net buyer of this stock at current levels. Its a great company no doubt, but its not a great investment at the moment.
Now here is a new gospel when it comes to insurance play. For plain corporate action aka special situation, you can consider Pan African, both before the book closure on bonus and div. and after the book closure. Why? Well its simple. They are selling their 40% stake in APA. What's that in shilling value? Depends on your valuations for APA. Now based on how we value insurance companies,(Float and its cost!) and book value measures, you would have a best case scenario of 1.7bn(40% on assumptions that it has a 95 underwriting margin and investment income using 3yr averages), mild scenario of 700m(40% on assumptions that 95 underwriting margins and investments are made only in long term government bonds), or worst case of 420m(420m is based on 40% of book-value end of 2009). That would provide support for the stock and will be a catalyst for a great dividend in the next financial year. So your overall returns could be well in excess of 40-50% for the year. We dont believe in stock tips but we think this would be great. The better thing is for the price to go below 90.
The other alternative for the long haul is Kenya Re. am more than certain that this stock will reward the patient ones. Jubilee at below 110, would be a steal, but what are the odds for those who lack it in the portfolio?
Disclaimer:
These are personal views and are in no ways stock recommendations